Apply for Your Opportunity to Compete in This Year's Start-Up Stadium

 

Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology partnering event. During the 2023 BIO International Convention select finalists from around the world will share a quick pitch showcasing new technologies and therapeutic solutions to a panel of investor judges, followed by live feedback. Finalists will be eligible for a highly discounted registration rate to attend the 2023 BIO International Convention. 

This year will also feature evaluation of the presentations from seed-stage company finalists (less than $1M raised) separate from emerging company finalists (more than $1M but less than $10M raised to date). with a winner identified for each category. Past prizes have included 'fast-track' admission review to incubator programs at the Illumina Accelerator and The Innovation Space, as well as complimentary, one-year memberships in the Biotechnology Innovation Organization with access to the cost-savings programs of BIO Business Solutions

 

We will be accepting applications until 11:59 PM ET on February 15, 2023. There is no cost to apply.

 

Typical Requirements for Applicants:

  • Raised less than $10 million since inception
  • Fewer than 20 full-time employees
  • Previous business pitch or competition experience
  • Must not be a previous Start-Up Stadium winner

 

 

Congratulations to our 2022 Emerging and Seed-Stage Winners
2022 Emerging Start-Up Winner

SiVEC Biotechnologies

Fort Collins, Colorado

2022 Seed-Stage Start-Up Winner

OncoXome

Los Angeles, California

Need Additional Information?

Download our pitch presentation guide for additional insight and advice on building a stellar submission,

Thank You to our 2022 Finalists

nVector, Inc. - Therapeutics and Vaccines - United States (Arizona)    
PrecisemAb Biotech Co., Ltd. - Therapeutics and Vaccines - Taiwan    
BacVax, Inc. - Therapeutics and Vaccines - United States (Arizona)    
South Rampart Pharma - Therapeutics and Vaccines - United States (Louisiana)
Nixxi - Digital Health - United States (Arizona)
Limax Biosciences - Medical Device - United States (Massachusetts)    
Evrima Technologies Pty Ltd - Platform Technology - Australia    
My Medic Watch Pty Ltd - Digital Health - Australia    
Pharmasaga - Therapeutics and Vaccines - Taiwan    
Curiva – Diagnostics - United States (Indiana)
MyoGene Bio - Therapeutics and Vaccines - United States (California)    
Nano PharmaSolutions, Inc. - Platform Technology - United States (California)    
BlackweRx Inc. - Platform Technology - United States (Texas)    
Navega Therapeutics, Inc. - Therapeutics and Vaccines - United States (California) 
NeurANO Bioscience - Therapeutics and Vaccines - United States (California)    
EpiVario Inc - Therapeutics and Vaccines - United States (Pennsylvania)    
MabSwitch Inc - Therapeutics and Vaccines - United States (California)
Pyrefin Inc. - Therapeutics and Vaccines - United States (Georgia)
APIE Therapeuctics - Therapeutics and Vaccines - United States (North Carolina)    
NextVivo - Platform Technology - United States (California)
Centivax Inc - Therapeutics and Vaccines - United States (California)

Coastar Therapeutics Inc. - Platform Technology - United States (California)
Ophidion, Inc. - Therapeutics and Vaccines - United States (Pennsylvania)
TRIO Pharmaceuticals, Inc. - Therapeutics and Vaccines - United States (California)
AcureX Therapeutics - Therapeutics and Vaccines - United States (California)
Aza Technology, Inc. - Medical Device - United States (Maryland)    
Halo Biosciences - Therapeutics and Vaccines - United States (California)    
MEDIC Life Sciences - Therapeutics and Vaccines - United States (California)    
Parallel Bio - Therapeutics and Vaccines - United States (California)
Vcreate - Therapeutics and Vaccines - United States (California)
Santa Maria Lab - Therapeutics and Vaccines - United States (California)
Crista Biologics - Therapeutics and Vaccines - United States (California)
NeuroDex, Inc. – Diagnostics - United States (Massachusetts)    
QUASR Diagnostics
– Diagnostics - United States (New Mexico)    
Avida Biomed Inc.
– Diagnostics - United States (California)
Moleculera Labs – Diagnostics - United States (Oklahoma)
Nanochon - Medical Device - United States (District Of Columbia)    
Pathogenomix Inc.
– Diagnostics - United States (California)
Rewire Neuro, Inc – Diagnostics - United States (Oregon)    
Switchback Systems, Inc. - Digital Health - United States (California)

 

Thank You to our 2022 Start-Up Stadium Judges

  • Orrin Ailloni-Charas, MD, MBA, Managing Partner, Cura Capital
  • Christopher Aleong, Chief Business Officer, Lumosa Therapeutics
  • John Behr, Partner, SV Health Investors
  • James Buxton, Senior Associate, NEA
  • Joseph Charalel, Senior Associate, Pivotal bioVenture Partners (US)
  • David H. Crean, Managing General Partner, Cardiff Advisory LLC
  • Bettina Ernst, Director, BERNINA BioInvest
  • David Fox, Co-founder, Modality.ai
  • Yinghong Gao, Venture Partner, Viva BioInnovator
  • Juliet Gomez, Program Manager, Flinn Foundation
  • Gábor Gyülvészi, Sr. Associate, Nextech Invest AG
  • Lu Han, Partner, Lumira Ventures
  • Daniel Jacobs, Managing Director, Pathway Bioventures
  • Scott M. Kahn, PhD, Founder, Alykomed Global Solutions LLC
  • Vince Kohli, Global Tech Impact Capitalist, Trillion Ventures Global Capital Fund
  • Benjamin Li, Senior Associate, Pivotal bioVenture Partners (US)
  • David Malek, Venture Partner, Pivotal bioVenture Partners (US)
  • Marc Martin-Casas, Head of Illumina Accelerator, San Francisco, Illumina Accelerator
  • Laurie K. McNamara, PhD, Esq., Associate, Wilson Sonsini Goodrich & Rosati
  • Miguel A. Mendez, Managing Director, Facultas Partners
  • Mariana Mihalusova, Vice President, Venrock
  • Sandra Miller, General Partner, Cura Capital
  • Graham Mills, Investment Manager, Abingworth LLP
  • Ivan Morace, Senior Investment Analyst, MediVentures GmbH
  • Anton Neschadim, Senior Advisor, GreenSky Capital
  • Younes Ouahid, Partner, Facultas Partners
  • William D. Provine, PhD, President & CEO, Innovation Space
  • Marcie Reilly, Program Manager, Partnerships & Special Projects, Innovation Space
  • Catello Somma, Associate, TVM Capital Life Science Management GmbH
  • Lesley Stolz, PhD, VP, Early Innovation Partnering, Johnson & Johnson Innovation
  • Nilay Thakar, Principal, ARCH Venture Partners
  • Anton Xavier, Director, Early Stage Life Science Banking, SVB
  • Kitty Wu, VP, Head of Business Development and Strategy, Fosun Pharma USA
  • Samuel Wu, Venture Partner, 7G BioVentures
  • Xiangbin Xu, CEO, QLD Biotherapeutics Inc
  • Wenping Zhou, Investment Associate, CT innovations
  • John Zhu, Founder and President, Mayewell Capital